For the Inventor, By the Inventor

Enter assignee name

Genmont Biotech Incorporation

USPTO Granted Patents = 15

EPO Patents = 1

Forward Citations = 7

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Yi-Hsing Chen (11 out of 19 patents)

Wan-Hua Tsai (11 out of 18 patents)

Chia-Hsuan Chou (3 out of 7 patents)

4. Wen-Ling Yeh (3 out of 4 patents)

5. Tsuei-Yin Huang (3 out of 3 patents)

6. Wen-Wei Chang (2 out of 2 patents)

7. Chih-Yang Huang (2 out of 4 patents)

8. Wei-Wen Kuo (2 out of 2 patents)

9. Bor-Show Tzang (2 out of 2 patents)

10. Chih-Ho Lai (2 out of 4 patents)

11. Feng-Ching Hsieh (2 out of 6 patents)

12. Ying-Chen Lu (2 out of 2 patents)

13. Yu-Hsin Lin (1 out of 11 patents)

14. Ying-Ju Chiang (1 out of 2 patents)

15. Ya-Hui Chen (1 out of 4 patents)

15 patents: Sort by Forward Citations

1. 12508290 - Use ofGMNL-346 for anti-oral cancer treatment and thereof (2025-12-30),

2. 12343364 - GMNL-263 for improving hypertension and its compositions thereof (2025-07-01),

3. 12012589 - composition and use thereof for improving anxiety caused by antibiotics (2024-06-18),

4. 11889835 - Plant growth regulator of elevating anti-stress ability and use thereof (2024-02-06),

5. 11318176 - Topical composition, pharmaceutical composition containing inactivated culture and method of facilitating wound healing and scar reduction using the same (2022-05-03),

6. 11007137 - Use of lactobacillus plantarum GMNL-6 composition for skin care (2021-05-18),

7. 10646522 - strain, composition and use thereof for treating syndromes and related complications of autoimmune diseases (2020-05-12),

8. 10639336 - Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke (2020-05-05),

9. 10638784 - Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof (2020-05-05),

10. 10632160 - Probiotic composition for preventing, improving or alleviating pancreatic cancer and application thereof (2020-04-28),

11. 10555979 - Use ofGMNL-653 for preparing for a composition for alleviating axillary osmidrosis (2020-02-11),

12. 10456430 - Lactobacillus composition for prevention and treatment of bacterial vaginosis (2019-10-29),

13. 9980990 - [object Object] (2018-05-29),

14. 8753624 - [object Object] (2014-06-17),

15. 7901926 - [object Object] (2011-03-08),

GenMont Biotech Incorporation is a leading biotechnology company specialized in the development and commercialization of innovative genomic solutions. With a team of dedicated scientists and cutting-edge technologies, we aim to reshape the future of healthcare and agriculture by providing breakthrough genetic tools and services. Our mission is to empower scientists, physicians, and farmers with advanced genomic solutions that enable better disease detection, personalized medicine, and sustainable agriculture practices. By combining our expertise in genomics with state-of-the-art bioinformatics and data analysis, we accelerate research, drive innovation, and deliver actionable insights for a healthier and more sustainable world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#64 in Tainan

#1,018 in Taiwan

#38,723 in the World

Genmont Biotech Incorporation

Forward Citations = 7

32 inventors:

Yi-Hsing Chen (11 out of 19 patents)

Wan-Hua Tsai (11 out of 18 patents)

Chia-Hsuan Chou (3 out of 7 patents)

4. Wen-Ling Yeh (3 out of 4 patents)

5. Tsuei-Yin Huang (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…